We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we are going to take a look at ...

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...

Pfizer trades at a 21.7% discount to peers on a 1-yr forward P/E basis, which is a point for the bullish arguments. Find out ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

On Friday, Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.36 which represents a slight increase of $0.59 or 2.29% from the prior close of $25.77. The stock opened at $ and touched a ...

As of the latest trading close, PFE, a Healthcare sector stock, is trading -18.90% below its 52-week high but remains 4.49% above its 52-week low. The Average True Range (ATR) (14 days) of 0.55 ...

Dividend-paying stocks provide investors with consistent income in turbulent markets, especially as payouts grow over time.

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best stocks to buy and hold for 3 years. On December 12, Tom Lee, Fundstrat Global Advisors ...

Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the ...

In a report released yesterday, Steve Scala from TD Cowen maintained a Hold rating on Pfizer (PFE – Research Report). The company’s shares ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...